Sotera Health (SHC) EV to EBITDA (2020 - 2026)

Sotera Health has reported EV to EBITDA for 7 years, with the latest figure at 42.88 in Q2 2026.

• On a quarterly basis, EV to EBITDA rose 48.38% year-over-year to 42.88 in Q2 2026; TTM through Jun 2026 was 11.45, a 36.89% increase from a year earlier, with the FY2025 full-year figure at 11.89, down 1.67% from the prior year.
• EV to EBITDA was 42.88 for Q2 2026 at Sotera Health, down from 47.85 in the prior quarter.
• The five-year high for EV to EBITDA was 131.86 in Q1 2023, with the low at 27.84 in Q3 2022.
• Average EV to EBITDA over 5 years is 55.09, with a median of 43.0 recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: EV to EBITDA slumped 74.9% in 2022, then jumped 87.95% in 2023.
• Over 5 years, EV to EBITDA stood at 32.51 in 2022, then soared by 31.99% to 42.91 in 2023, then slipped by 3.76% to 41.3 in 2024, then increased by 4.31% to 43.08 in 2025, then fell by 0.46% to 42.88 in 2026.
• The last three EV to EBITDA figures came in at 42.88 (Q2 2026), 47.85 (Q1 2026), and 43.08 (Q4 2025), per Business Quant data.